Solid Biosciences Inc. Interest Expense
Solid Biosciences Inc. (SLDB) reported Interest Expense of $88.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-13
- Solid Biosciences Inc. interest expense for the quarter ending 2024-06-30 was $88.00K, a 20.72% decline year-over-year.
- Solid Biosciences Inc. interest expense for the quarter ending 2024-03-31 was $95.00K, a 21.49% decline year-over-year.
- Solid Biosciences Inc. interest expense for the quarter ending 2023-06-30 was $111.00K.
- Solid Biosciences Inc. interest expense for the quarter ending 2023-03-31 was $121.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2024-06-30 | $88.00K 10-Q · filed 2024-08-13 | $183.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $95.00K 10-Q · filed 2024-05-15 | |
| 2023-06-30 | $111.00K 10-Q · filed 2024-08-13 | $233.00K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $121.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |